Literature DB >> 30680775

Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.

Erik L Bao1,2,3, Caleb A Lareau1,2,4, Carlo Brugnara5, Isabel R Fulcher6, Caroline Barau7, Stephane Moutereau8, Anoosha Habibi9, Bouchra Badaoui10, Jugurtha Berkenou9, Pablo Bartolucci9, Frédéric Galactéros9, Orah S Platt5, Michael Mahaney11, Vijay G Sankaran1,2.   

Abstract

Sickle cell disease (SCD) is the most common monogenic disorder in the world. Notably, there is extensive clinical heterogeneity in SCD that cannot be fully accounted for by known factors, and in particular, the extent to which the phenotypic diversity of SCD can be explained by genetic variation has not been reliably quantified. Here, in a family-based cohort of 449 patients with SCD and 755 relatives, we first show that 5 known modifiers affect 11 adverse outcomes in SCD to varying degrees. We then utilize a restricted maximum likelihood procedure to estimate the heritability of 20 hematologic traits, including fetal hemoglobin (HbF) and white blood cell count (WBC), in the clinically relevant context of inheritance from healthy carriers to SCD patients. We report novel estimations of heritability for HbF at 31.6% (±5.4%) and WBC at 41.2% (±6.8%) in our cohort. Finally, we demonstrate shared genetic bases between HbF, WBC, and other hematologic traits, but surprisingly little overlap between HbF and WBC themselves. In total, our analyses show that HbF and WBC have significant heritable components among individuals with SCD and their relatives, demonstrating the value of using family-based studies to better understand modifiers of SCD.
© 2019 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30680775      PMCID: PMC6449202          DOI: 10.1002/ajh.25421

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  23 in total

1.  Smoking is associated with an increased risk of acute chest syndrome and pain among adults with sickle cell disease.

Authors:  Robyn T Cohen; Michael R DeBaun; Morey A Blinder; Robert C Strunk; Joshua J Field
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

2.  Phenotype/genotype relationships in sickle cell disease: a pilot twin study.

Authors:  M W Weatherall; D R Higgs; H Weiss; D J Weatherall; G R Serjeant
Journal:  Clin Lab Haematol       Date:  2005-12

Review 3.  Sickle Cell Disease.

Authors:  Frédéric B Piel; Martin H Steinberg; David C Rees
Journal:  N Engl J Med       Date:  2017-04-20       Impact factor: 91.245

4.  Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children.

Authors:  Jeremie H Estepp; Matthew P Smeltzer; Winfred C Wang; Mary E Hoehn; Jane S Hankins; Banu Aygun
Journal:  Br J Haematol       Date:  2013-02-06       Impact factor: 6.998

5.  Sickle cell-hereditary persistence of fetal haemoglobin and its differentiation from other sickle cell syndromes.

Authors:  N Murray; B E Serjeant; G R Serjeant
Journal:  Br J Haematol       Date:  1988-05       Impact factor: 6.998

6.  Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation.

Authors:  Geneviève Galarneau; Cameron D Palmer; Vijay G Sankaran; Stuart H Orkin; Joel N Hirschhorn; Guillaume Lettre
Journal:  Nat Genet       Date:  2010-11-07       Impact factor: 38.330

7.  Genetic influences on F cells and other hematologic variables: a twin heritability study.

Authors:  C Garner; T Tatu; J E Reittie; T Littlewood; J Darley; S Cervino; M Farrall; P Kelly; T D Spector; S L Thein
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

8.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

9.  Disease Heritability Inferred from Familial Relationships Reported in Medical Records.

Authors:  Fernanda C G Polubriaginof; Rami Vanguri; Kayla Quinnies; Gillian M Belbin; Alexandre Yahi; Hojjat Salmasian; Tal Lorberbaum; Victor Nwankwo; Li Li; Mark M Shervey; Patricia Glowe; Iuliana Ionita-Laza; Mary Simmerling; George Hripcsak; Suzanne Bakken; David Goldstein; Krzysztof Kiryluk; Eimear E Kenny; Joel Dudley; David K Vawdrey; Nicholas P Tatonetti
Journal:  Cell       Date:  2018-05-17       Impact factor: 41.582

10.  Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?

Authors:  D R Powars; J N Weiss; L S Chan; W A Schroeder
Journal:  Blood       Date:  1984-04       Impact factor: 22.113

View more
  3 in total

1.  Sickle cell disease in the era of precision medicine: looking to the future.

Authors:  Martin H Steinberg; Sara Kumar; George J Murphy; Kim Vanuytsel
Journal:  Expert Rev Precis Med Drug Dev       Date:  2019-11-07

2.  Improved Titer and Gene Transfer by Lentiviral Vectors Using Novel, Small β-Globin Locus Control Region Elements.

Authors:  Richard A Morgan; Mildred J Unti; Bamidele Aleshe; Devin Brown; Kyle S Osborne; Colin Koziol; Paul G Ayoub; Oliver B Smith; Rachel O'Brien; Curtis Tam; Eric Miyahira; Marlene Ruiz; Jason P Quintos; Shantha Senadheera; Roger P Hollis; Donald B Kohn
Journal:  Mol Ther       Date:  2019-09-28       Impact factor: 11.454

Review 3.  The genetics of human hematopoiesis and its disruption in disease.

Authors:  Erik L Bao; Aaron N Cheng; Vijay G Sankaran
Journal:  EMBO Mol Med       Date:  2019-07-17       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.